Cardiovascular Intervention

Contributing journals to this collection:
JAMA & Archives Journals

Citations 331-340 of 842 total displayed.

Past content

JAMA Patient Page
Implantable Cardioverter-Defibrillators

Janet M. Torpy; Alison E. Burke; Richard M. Glass
JAMA 2006; 295: 1964. [Extract] [Full text] [PDF] [ Spanish PDF ]  

Original Investigations
Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin: Assessment of Incidence, Case-Fatality Rate, Time Course and Sites of Bleeding, and Risk Factors for Bleeding

James D. Douketis; Karin Arneklev; Samuel Z. Goldhaber; John Spandorfer; Frank Halperin; Jay Horrow
Arch Intern Med 2006; 166: 853-859. [Abstract] [Full text] [PDF]  

Letters
Efficacy and Safety of Edifoligide

George T. Lau; Leonard Kritharides
JAMA 2006; 295: 1513-a-1514-a. [Extract] [Full text] [PDF]  

Letters
Efficacy and Safety of Edifoligide

Alessandro Parolari; Francesco Alamanni; Elena Tremoli; Paolo Biglioli
JAMA 2006; 295: 1513. [Extract] [Full text] [PDF]  

Letters
Efficacy and Safety of Edifoligide—Reply

John H. Alexander; Robert A. Harrington; T. Bruce Ferguson; Eric D. Peterson; C. Michael Gibson; Nicholas T. Kouchoukos; for the PREVENT IV Investigators
JAMA 2006; 295: 1514-a-1515-a. [Extract] [Full text] [PDF]  

Letters
Efficacy and Safety of Edifoligide

Nimesh D. Desai; Stephen E. Fremes
JAMA 2006; 295: 1514. [Extract] [Full text] [PDF]  

Research Letters
Interaction of Duloxetine and Warfarin Causing Severe Elevation of International Normalized Ratio

Charles J. Glueck; Qasim Khalil; Magdalena Winiarska; Ping Wang
JAMA 2006; 295: 1517-1518. [Extract] [Full text] [PDF]  

Original Contributions
Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial

The OASIS-6 Trial Group*
JAMA 2006; 295: 1519-1530. [Abstract] [Full text] [PDF]  

Original Contributions
Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: The ISAR-REACT 2 Randomized Trial

Adnan Kastrati; Julinda Mehilli; Franz-Josef Neumann; Franz Dotzer; Jurriën ten Berg; Hildegard Bollwein; Isolde Graf; Maryam Ibrahim; Jürgen Pache; Melchior Seyfarth; Helmut Schühlen; Josef Dirschinger; Peter B. Berger; Albert Schömig; for the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 (ISAR-REACT 2) Trial Investigators
JAMA 2006; 295: 1531-1538. [Abstract] [Full text] [PDF]  

Editorials
Fondaparinux in ST-Segment Elevation Myocardial Infarction: The Drug, the Strategy, the Environment, or All of the Above?

Robert M. Califf
JAMA 2006; 295: 1579-1580. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85